CSKUnlisted Shares
₹ 248▲19.23%(40.00)
About the company
Chennai Super Kings
Chennai Super Kings (CSK), founded in 2008, is one of the most successful and widely recognized franchises in the Indian Premier League (IPL). Based in Chennai, the team plays its home matches at the M.A. Chidambaram Stadium and has built a strong fan base over the years.
CSK has established itself as a leading IPL franchise through consistent performances and multiple championship victories. The franchise made a memorable comeback in 2018 after a two-season suspension and went on to win the IPL title that same year. Its continued success on the field, combined with strong brand recognition and a loyal fan following, has helped CSK become one of the prominent franchises in Indian cricket.
In 2014, India Cements approved the demerger of the CSK franchise into Chennai Super Kings Cricket Limited (CSKCL), with the arrangement becoming effective in 2015. Following the restructuring, eligible India Cements shareholders received shares in the newly formed company under the applicable demerger arrangement.
Today, Chennai Super Kings unlisted shares attract interest from investors looking for exposure to the growing commercial ecosystem around the IPL and professional sports in India. However, as with any unlisted investment, investors should carefully evaluate the CSK unlisted share price, company financials, valuation, liquidity, and associated risks before making an investment decision.
Fundamentals
Valuation
- 52 week high
- ₹312
- 52 week low
- ₹174
- P/B ratio
- 13.31
- Debt to equity
- 0.01
- ROE (%)
- 20.65%
- Book value
- ₹18.93
- Face value
- ₹0.1
- Valuation
- —
Registry
- PAN number
- AAFCC8730K
- ISIN number
- INE852S01026
- CIN
- U74900TN2014PLC098517
Figures in lk ·
Financials
| P&L Statement | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 34105 | 27315 | 69545 | 67380 |
| EBITDA | 4133 | 6502 | 26363 | 19137 |
| OPM | 12.12 | 23.8 | 37.91 | 28.4 |
| PBT | 4133 | 7053 | 27916 | 20951 |
| PAT | 3213 | 5218 | 20150 | 14832 |
| EPS | 1.04 | 1.69 | 5.32 | 3.91 |
Shareholding Pattern
Leadership
| Name | Role | Experience | |
|---|---|---|---|
| N. Srinivasan | Chairman | 30 yrs experience | |
| K.S.Viswanathan | CEO | 33 yrs experience | — |
Frequently asked questions
Common questions on CSK Unlisted Shares—tap a row to read the answer.
Q.1What are CSK Unlisted Shares?
CSK Unlisted Shares are equity shares of Chennai Super Kings Cricket Limited (CSKCL) that are not currently listed and traded on stock exchanges such as NSE or BSE. Investors can buy and sell these shares through the unlisted share market, subject to availability and applicable transfer procedures.
These shares give investors an opportunity to own a stake in the company behind the Chennai Super Kings franchise. However, since they are unlisted securities, investors should carefully consider factors such as company valuation, liquidity, financial performance, and associated risks before investing.
Q.2How can I buy CSK Unlisted Shares?
If you are planning to buy CSK unlisted shares, you can purchase them through an intermediary dealing in unlisted securities. You generally need an active Demat account, PAN, and completed KYC documentation.
Once you check the latest CSK unlisted shares price and confirm the quantity you want to purchase, you can proceed with the transaction. After the required payment and settlement process is completed, the shares are transferred to your Demat account.
Before investing, make sure you understand the current valuation and verify all transaction details.
Q.3What is the latest CSK Unlisted Share Price?
The CSK unlisted share price can change based on demand and supply in the unlisted market, availability of shares, company performance, financial results, and overall investor interest.
Unlike listed stocks, there is no single live price available on NSE or BSE. Therefore, investors looking for the latest Chennai Super Kings share price should check the current market quote before buying or selling. The final transaction price may vary depending on the quantity and prevailing market conditions.
Q.4What is the minimum investment required to buy CSK Unlisted Shares?
The minimum investment required for CSK Unlisted Shares depends on the current share price and the minimum quantity available for purchase.
For example, if there is a minimum quantity set for a particular transaction, your total investment will be calculated based on the agreed price per share multiplied by the number of shares purchased. Investors should check the latest minimum ticket size and share availability before placing an order.
Q.5How can I sell my CSK Unlisted Shares?
If you already own CSK Unlisted Shares and wish to sell them, you can approach an intermediary dealing in unlisted securities and check the current buying price.
Once you agree on the price and quantity, the shares are transferred from your Demat account to the buyer as per the applicable settlement process. Payment is then made according to the agreed transaction terms.
Since unlisted shares are not traded on a regular stock exchange, liquidity may be lower, and the selling price can depend on buyer demand at the time of the transaction.
Q.6How is DIS used to sell CSK Unlisted Shares?
A Delivery Instruction Slip (DIS) can be used to transfer CSK Unlisted Shares from your Demat account to another Demat account when completing a sale.
The seller generally needs to provide details such as the ISIN, quantity of shares, and recipient's Demat account information. Depending on your Depository Participant (DP), an electronic transfer facility may also be available.
Always verify the recipient's details carefully before authorizing the transfer.
Trending shares
High-demand unlisted opportunities currently available for trade.
From the blog
Notes on unlisted markets, execution hygiene, and how we think about risk—no hype, no ticker spam.

APTUS PHARMA IPO
Aptus Pharma Limited rolled out its 100% book-built BSE SME public offering worth ₹13.02 Crore. Review crucial parameters for retail investors, featuring the ₹65–₹70 price band, working capital allocations, and an evaluation of its contract-manufacturing partner model.

NEPHROPLUS (NEPHROCARE HEALTH SERVICES) IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

APOLLO TECHNO INDUSTRIES IPO
Apollo Techno Industries Limited has announced its public offering details. Explore the essential investment parameters for retail and institutional bidders, highlighting the fixed price band, lot structure, key market deadlines, and an overview of its industrial manufacturing footprint.

NEOCHEM BIO IPO
Explore the Neochem Bio IPO, including issue details, business strengths, risks, and investment analysis.

ANONDITA MEDICARE IPO
Anondita Medicare Limited rolled out its 100% book-built SME public offering worth ₹69.50 Crore on the NSE SME platform. Dig into the critical parameters for investors, highlighting the ₹137–₹145 price band, key working capital objectives, and an analysis of its flagship brand 'COBRA' within the growing sexual wellness market.

NEPTUNE LOGITEK IPO
Explore the Neptune Logitek IPO, including issue details, business strengths, risks, and investment analysis.
